A 48-year-old man with chronic kidney disease (eGFR 35 mL/min/1.73m²) and hypertension develops progressive left ventricular hypertrophy. His serum potassium is 4.8 mEq/L and creatinine is 2.1 mg/dL. Which agent is the preferred first-line choice to promote LVH regression while providing renal protection?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.